Search
Twist Bioscience Corp
TWSTAdd to Watchlist
166.990USD
+11.430+7.35%
Close 09-18 16:00（ET）
10.46BMarket Cap
LossP/E TTM
Twist Bioscience Corp (TWST) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Twist Bioscience Corp in the past month.
Buy
5 Strong Buy
4 Buy
1 Hold
1 Sell
0 Strong Sell
Target Price
109.500USD-20.71%
TWST Analyst Recommendation Trends
In the current month, TWST has received 4 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. TWST average Analyst price target in the last month is 109.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
6
5
5
5
5
4
4
5
3
4
4
4
4
1
1
0
0
1
2
2
2
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
11
10
10
9
10
11
11
11
TWST Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
9
21
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Financial Forecasting
Based on analysts' estimates, TWST EPS is projected to reach -0.374 in FY2026Q4, following reported EPS of -0.562 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.43
-0.48
-0.49
-0.37
-0.39
Actual
-0.50
-0.71
-0.56
--
--
Surprise
-16.15%
-49.44%
-13.76%
--
--
FAQs
What is Twist Bioscience Corp's expected revenue for the next quarter?
Twist Bioscience Corp's expected revenue is 122.46M.
What is Twist Bioscience Corp's price target?
Analysts forecast that Twist Bioscience Corp's price target is USD 109.50, with the highest forecast at USD 148.00 and the lowest forecast at USD 45.00.
How have Twist Bioscience CorpTWST's recent earnings per share performed?
The market expectation was USD -0.56, while Twist Bioscience CorpTWST's earnings per share (EPS) for the previous quarter was USD -0.71. EPS for the next quarter is expected at USD -0.37.
What is the analyst rating for Twist Bioscience Corp?
Based on the ratings of Twist Bioscience Corp's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.